On June 2, a startup called NewLimit, founded by the crypto billionaire Brian Armstrong, said it had raised a further $435 million, from investors including Peter Thiels Founders Fund, to support what it calls age reprogramming. The company says it is working toward delivering genetic reprogramming instructions to the liver, to treat diseases of that organ
Because the drug raises heart rate and blood pressure, the article calls it unsuitable for people with cardiovascular risk factors generally
Encourages a pro-growth micro-environment, tipping signals toward active growth and away from inhibitory cues
This helps the mitochondria (the powerhouses of the cell) to produce cell energy effectively and the cells to maintain a healthy metabolism
absorbed, making Liposomal delivery the only viable option
Weight loss with tirzepatide typically occurs gradually over months, and testosterone's effects on symptoms may take several weeks to months to manifest fully
